Search - tctmd.com

Displaying 41 - 60 of 65

Sort: Relevancy | Date

News Daily News

CMS Pays More to Male Cardiologists, but the Reasons Why Are Murky

Michael O'Riordan

September 10, 2021

News Conference News ESC 2021

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Michael O'Riordan

September 03, 2021

News Daily News

Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns

Shelley Wood

July 20, 2021

News Daily News

Myocarditis in Young People After mRNA COVID-19 Vaccination Higher Than Expected

Michael O'Riordan

June 11, 2021

News Daily News

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

Michael O'Riordan

January 12, 2021

News Opinion Conversations in Cardiology

Conversations in Cardiology: Where to Build a Hybrid Lab

December 28, 2020

News Daily News

Echo Aids Diagnosis, Risk Prediction in Severe COVID-19

Shelley Wood

October 26, 2020

News Conference News SCCT 2020

Biggest Barriers to Cardiac CT? Old Myths, Fair Payment, and De-adoption

Yael L. Maxwell

July 22, 2020

Presentation JIM 2020

Case 1 – Retrograde approach by septal branches (to treat occlusive ISR)

Presenter: Mauro Carlino

February 12, 2020

News Daily News

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Caitlin E. Cox

January 20, 2020

News Conference News PCR London Valves 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

News Conference News TCT 2018

ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year

Lucy Hicks

September 24, 2018

Case #9: Under-Expanded Stent with ISR Treated by Laser, Atherectomy, or Lithotripsy

Presentation TCT 2018

Case #8: Under-Expanded Stent with ISR Treated by Laser, Atherectomy, or Lithotripsy

Presenter: Fernando Alfonso, Hiram G. Bezerra, Daniel Chamie, Lisette Okkels Jensen, Michael Joner, Gary S. Mintz, Lorenz Raber, Andrew Sharp

September 23, 2018

News Conference News ESC 2018

Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy

Michael O'Riordan

August 27, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

News Conference News AHA 2016

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

Michael O'Riordan

November 15, 2016

News Conference News AHA 2016

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Michael O'Riordan

November 14, 2016

News Conference News TCT 2016

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Michael O'Riordan

November 01, 2016

News Conference News TCT 2016

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Todd Neale

November 01, 2016

Advertisement

CMS Pays More to Male Cardiologists, but the Reasons Why Are Murky

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns

Myocarditis in Young People After mRNA COVID-19 Vaccination Higher Than Expected

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

Conversations in Cardiology: Where to Build a Hybrid Lab

Echo Aids Diagnosis, Risk Prediction in Severe COVID-19

Biggest Barriers to Cardiac CT? Old Myths, Fair Payment, and De-adoption

Case 1 – Retrograde approach by septal branches (to treat occlusive ISR)

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year

Case #8: Under-Expanded Stent with ISR Treated by Laser, Atherectomy, or Lithotripsy

Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content